Skip to main content

Advertisement

Log in

Intra-articular glucocorticoid injections and their effect on hypothalamic–pituitary–adrenal (HPA)-axis function

  • Mini Review
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

The use of intra-articular (IA) glucocorticoids for reducing pain and inflammation in patients with osteoarthritis, rheumatoid arthritis, and other inflammatory arthropathies is widespread among primary care physicians, specialists, and non-specialists in the United States. Injectable glucocorticoids have anti-inflammatory and analgesic properties which can be effective in improving clinical parameters such as pain, range of motion, and quality of life. After injection into the IA space, glucocorticoids may be systemically absorbed; the degree of absorption can depend on the size of the joint injected, the injectable glucocorticoid preparation used, the dosage, and the frequency of the injection. The adverse effects of intra-articular glucocorticoid injections (IAGC) can often be overlooked by both the patient and physicians who administer them, in particular the potential deleterious effect on the hypothalamic–pituitary−adrenal (HPA)-axis which can result in adrenal suppression and/or iatrogenic Cushing syndrome. In this paper we provide an overview on the often under-recognized effects of IAGC on HPA-axis function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. J.L. Hollander, E.M. Brown, R.A. Jessar, C.Y. Brown, Hydrocortisone and cortisone injected into arthritic joints: comparative effects of and use of hydrocortisone a local anti-arthritic agent. J. Am. Med. Assoc. 147(17), 1629–1635 (1951)

    Article  CAS  PubMed  Google Scholar 

  2. J.C. Snibbe, R.A. Gambardella, Use for injections in osteoarthritis in joints and sports activity. Clin. Sports Med. 24(1), 83–91 (2005)

    Article  PubMed  Google Scholar 

  3. J.R. Caldwell, Intra-articular corticosteroids. Guide for selection and indications for use. Drugs 52(4), 507–514 (1996)

    Article  CAS  PubMed  Google Scholar 

  4. O.T. Cheng, D. Souzdalnitski, B. Vrooman, J. Cheng, Evidence based knee injections for the management of arthritis. Pain. Med. 13(6), 740–753 (2012)

    Article  PubMed Central  PubMed  Google Scholar 

  5. D.H. Neustadt, Intra-articular injections for osteoarthritis of the knee. Clev. Clin. Journ. Med. 73(10), 897–911 (2006)

    Article  Google Scholar 

  6. M.C. Hochberg, D.L. Perlmutter, J.L. Hudson, R.D. Altman, Preferences in the management of osteoarthritis of the hip and knee:results of a survey of community based rheumatologist in the United States. Arthritis Care Res. 9(3), 170–176 (1996)

    Article  CAS  PubMed  Google Scholar 

  7. G.S. Habib, Systemic effects of intra-articular corticosteroids. Clin. Rheumatol. 28(7), 749–756 (2009)

    Article  PubMed  Google Scholar 

  8. J.M. Berthelot, B. Le Goff, Y. Maugars, Side effects of corticosteroid injections:whats new? Joint Bone Spine 80(4), 363–367 (2013)

    Article  CAS  PubMed  Google Scholar 

  9. B. Pekarek, L. Osher, S. Buck, M. Bowen, Intra-articular corticosteroid injections: a critical literature review with up-to-date findings. The Foot 21(2), 66–70 (2011)

    Article  PubMed  Google Scholar 

  10. B.J. Cole, H.R. Schumacher, Injectable corticosteroids in modern practices. J. Am. Acad. Ortho. Surg. 13(1), 37–46 (2005)

    Google Scholar 

  11. S. Ringold, P.F. Weiss, T. Beukelman, E.M. Dewitt, N.T. Llowite, Y. Kimura, R.M. Laxer, D.J. Lovell, P.A. Nigrovic, A.B. Robinson, R.K. Vehe, 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Care Res. 65(10), 1551–1563 (2013)

    Article  Google Scholar 

  12. B. Arroll, F. Goodyear-Smith, Corticosteroid injections for osteoarthritis of the knee:meta-analysis. BMJ 328, 869 (2004). doi:10.1136/bmj.38039.573970.7C

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. D.L. Scott, M. Shipley, A. Dawson, S. Edwards, D.P. Symmons, A.D. Woolf, The clinical management of rheumatoid arthritis and osteoarthritis:strategies for improving clinical effectiveness. Br. J. Rheumatol. 37(5), 546–554 (1998)

    Article  CAS  PubMed  Google Scholar 

  14. American Academy of Orthopaedic Surgeons. Treatment of osteoarthritis of the knee (non-arthroplasty). Full guidance www.aaos.org/research/guidelines/OAKguideline.PDF; Dec 2008

  15. A.G. Cleary, H.D. Murphy, J.E. Davidson, Intra-articular corticosteroid injections in juvenile idiopathic arthritis. Arch. Dis. Child. 88, 192–196 (2003)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. N. Bellamy, J. Campbell, V. Robinson, T. Gee, R. Bourne, G. Wells, Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Coch. Data. Syst. Rev. 19(2), CD005328 (2006)

    Google Scholar 

  17. M.B. Stephens, A.I. Beutler, F.G. O’Connor, Musculoskeletal injections: a review of the evidence. Am. Fam. Physician 78(8), 971–976 (2008)

    PubMed  Google Scholar 

  18. W. Lavelle, E.D. Lavelle, L. Lavelle, Intra-articular injection. Anesthesiol. Clin. 25(4), 853–862 (2007)

    Article  CAS  PubMed  Google Scholar 

  19. P. Creamer, Intra-articular corticosteroid injections in osteoarthritis:do they work and if so, how? Ann. Rheum. Dis. 56(11), 634–636 (1997)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. T. Tanabe, N. Tohnai, Cyclooxygenase isozymes and their gene structures and expression. Prostag. Oth. Lip. Med. 68, 95–114 (2002)

    Article  Google Scholar 

  21. I. Uthman, J.P. Raynauld, B. Haraoui, Intra-articular therapy in osteoarthritis. Postgrad. Med. J. 79(934), 449–453 (2003)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. D. Marsland, A. Mumith, I.W. Barlow, Systemic review: the safety of intra-articular corticosteroid injection prior to total knee arthroplasty. Knee 21(1), 6–11 (2014)

    Article  PubMed  Google Scholar 

  23. D. Czock, F. Keller, F.M. Rasche, U. Haussler, Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin. Pharmacokinet. 44(1), 61–98 (2005)

    Article  CAS  PubMed  Google Scholar 

  24. M.C. Lansang, T. Farmer, L. Kennedy, Diagnosing the unrecognized systemic absorption of intra-articular and epidural steroid injections. Endocr. Pract. 15(3), 225–228 (2009)

    Article  PubMed  Google Scholar 

  25. M.C. Lansang, L.K. Hustak, Glucocorticoid-induced diabetes and adrenal suppression:how to detect and manage them. Cleve. Clin. J. Med. 78(11), 748–756 (2011)

    Article  PubMed  Google Scholar 

  26. T.D. Rozental, T.P. Sculo, Intra-articular corticosteroids: an updated overview. Am. J. Orthop. 29(1), 18–23 (2000)

    CAS  PubMed  Google Scholar 

  27. H. Bergrem, The influence of uremia on pharmacokinetics and protein binding of prednisolone. Acta. Medica. Scand. 213(5), 333–337 (1983)

    Article  CAS  Google Scholar 

  28. B.M. Frey, F.J. Frey, Clinical pharmacokinetics of prednisone and prednisolone. Clin. Pharmakokinet. 19(2), 126–146 (1990)

    Article  CAS  PubMed  Google Scholar 

  29. M. Bartoszek, A.M. Brenner, S.J. Szefler, Prednisolone and methylprednisolone kinetics in children receiving anticonvulsant therapy. Clin. Pharmacol. Ther. 42(4), 424–432 (1987)

    Article  CAS  PubMed  Google Scholar 

  30. M. Maviki, P. Cowley, H. Marmery, Injecting epidural and intra-articular triamcinolone in HIV positive patients on ritonavir:beware of iatrogenic Cushing’s syndrome. Skeletal Radiol. 42(2), 313–315 (2013)

    Article  CAS  PubMed  Google Scholar 

  31. T. Weitoft, L. Ronnblom, Glucocorticoid resorption and influence on the hypothalamic-pituitary-adrenal axis after intra-articular treatment of the knee in resting and mobile patients. Ann. Rheum. Dis. 65(7), 955–957 (2006)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. R.D. Armstrong, J. English, T. Gibson, J. Chakraborty, V. Marks, Serum methylprednisolone levels following intra-articular injections of methylprednisolone acetate. Ann. Rheum. Dis. 40(6), 571–574 (1981)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  33. R.H. Straub, M. Cutolo, Involvement of the hypothalamic-pituitary-adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis. Viewpoint based on a systemic pathogenetic role. Arth. Rheum. 44(3), 493–507 (2001)

    Article  CAS  Google Scholar 

  34. E.F. Morand, M. Leech, Hypothalamic-pituitary-adrenal axis regulation of inflammation in rheumatoid arthritis. Immunol. Cell Biol. 79(4), 395–399 (2001)

    Article  CAS  PubMed  Google Scholar 

  35. M. Ostergaard, P. Halberg, Intra-articular glucocorticoid injections in joint diseases. Ugeskr. Laeger 161(5), 582–586 (1999)

    CAS  PubMed  Google Scholar 

  36. M. Duclos, M. Guinot, M. Colsy, F. Merle, C. Baudot, J.B. Corcuff, Y. Lebouc, High risk of adrenal insufficiency after a single articular steroid injection in athletes. Med. Sci. Sports. Exerc. 39(7), 1036–1043 (2007)

    Article  CAS  PubMed  Google Scholar 

  37. J. Snarr, Risk, benefits and complications of epidural steroid injections:a case report. AANA J. 75(3), 183–188 (2007)

    PubMed  Google Scholar 

  38. M.B. Lazarevic, J.L. Skosey, G. Djordjevic-Denic, W.I. Swedler, I. Zgardic, B.L. Myones, Reduction of cortisol levels after single intra-articular and intramuscular steroid injection. Am. J. Med. 99(4), 370–373 (1995)

    Article  CAS  PubMed  Google Scholar 

  39. H.I. Huppertz, H. Pfuller, Transient suppression of endogenous cortisol production after intra-articular steroid therapy for chronic arthritis in children. J. Rheumatol. 24(9), 1833–1837 (1997)

    CAS  PubMed  Google Scholar 

  40. D.M. Reid, C. Eastmond, J.A. Rennie, Hypothalamic pituitary−adrenal axis suppression after repeated intra-articular steroid injection. Ann. Rheum. Dis. 45(1), 87 (1986)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  41. M.M.O. Sullivan, W.R. Rumfeld, M.K. Jones, B.D. Williams, Cushing’s syndrome with suppression of the hypothalamic pituitary−adrenal axis after intra-articular steroid injections. Ann. Rheum. Dis. 44(8), 561–563 (1985)

    Article  Google Scholar 

  42. H. Derendof, H. Mollmann, A. Gruner, D. Haack, G. Gyselby, Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration. Clin. Pharmacol. Ther. 39(3), 313–317 (1986)

    Article  Google Scholar 

  43. R. Mader, L. Lavi, R. Luboshitzky, Evaluation of the pituitary−adrenal axis function following single intra-articular injection of methylprednisolone. Arth. Rheum. 52(3), 924–928 (2005)

    Article  CAS  Google Scholar 

  44. K.E. Muhlendahl, B. Weber, R. Muller-Hess, S. Korth-Schutz, H. Helge, Glucocorticoids and growth hormone secretion under physiological conditions and in states of steroid excess. Eur. J. Ped. 128(2), 113–121 (1978)

    Article  CAS  Google Scholar 

  45. E. McGuire, Sudden loss of milk supply following high dose triamcinolone (Kenacort) injection. Breastfeed. Rev. 20(1), 32–34 (2012)

    PubMed  Google Scholar 

  46. T. Weitoft, A. Larsson, L. Ronnblom, Serum levels of sex steroid hormones and matrix metalloproteinases after intra-articular glucocorticoid treatment in female patients with rheumatoid arthritis. Ann. Rheum. Dis. 67(3), 422–424 (2008)

    Article  CAS  PubMed  Google Scholar 

  47. M.H. Andrews, S.A. Wood, R.J. Windle, S.L. Lightman, C.D. Ingram, Acute glucocorticoid administration rapidly suppresses basal and stress induced hypothalamic-pituitary−adrenal axis activity. Endocrinology 153(1), 200–211 (2012)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  48. D.H. Schweitzer, P.P. Le-Brun, S. Krishnaswami, H. Derendorf, Clinical and pharmacological aspects of accidental triamcinolone acetonide overdose;a case study. Neth. J. Med. 56(1), 12–16 (2000)

    Article  CAS  PubMed  Google Scholar 

  49. H.A. Bird, E.F. Ring, P.A. Bacon, A thermographic and clinical comparison of three intra-articular steroid preparations in rheumatoid arthritis. Ann. Rheum. Dis. 38(1), 36–39 (1979)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  50. M. Magnotti, M. Shimshi, Diagnosing adrenal insufficiency:which test is best-the 1 µg or the 250-µg cosyntropin stimulation test? Endocrin. Pract. 14(2), 233–238 (2008)

    Article  Google Scholar 

  51. G. Habib, A. Jabbour, S. Artul, G. Hakim, Intra-articular methylprednisolone acetate injection at the knee joint and the hypothalamic-pituitary-adrenal axis: a randomized controlled study. Clin. Rheumatol. 33(1), 99–103 (2014)

    Article  PubMed  Google Scholar 

  52. G. Habib, S. Artul, M. Chernin, G. Hakim, A. Jabbour, The effect of intra-articular injection of betamethasone acetate/betamethasone sodium phosphate at the knee joint on the hypothalamic-pituitary-adrenal axis: a case controlled study. J. Investig. Med. 61(7), 1104–1107 (2013)

    CAS  PubMed  Google Scholar 

  53. G. Habib, F. Khazin, A. Jabbour, M. Chernin, S. Badarny, J. Hakim, S. Artul, Simultaneous bilateral knee injection of methylprednisolone acetate and the hypothalamic pituitary−adrenal axis: a single blind case control study. J. Invest. Med. 62(3), 621–626 (2014)

    CAS  Google Scholar 

  54. B.M. Kudielka, C. Kirschbaum, Awakening cortisol responses are influenced by health status and awakening time but not by menstrual cycle phase. Psychoneur. 28(1), 35–47 (2003)

    Article  CAS  Google Scholar 

  55. C.J. Tornhage, Salivary cortisol for assessment of hypothalamic-pituitary-adrenal axis function. NeuroImm. Mod. 16(5), 284–289 (2009)

    Article  Google Scholar 

  56. H. Raff, Utility of salivary cortisol measurements in Cushings syndrome and adrenal insufficiency. J. Clin. Endocrinol. Metab. 94(10), 3647–3655 (2009)

    Article  CAS  PubMed  Google Scholar 

  57. M.H. Laudat, S. Cerdas, C. Fournier, D. Guiban, B. Guilhaume, J.P. Luton, Salivary cortisol measurement: a practical approach to assess pituitary-adrenal function. J. Clin. Endocrinol. Metab. 66(2), 343–348 (1988)

    Article  CAS  PubMed  Google Scholar 

  58. W.J. Inder, G. Dimeski, A. Russell, Measurement of salivary cortisol in 2012-laboratory techniques and clinical indications. Clin. Endocrinol. 77(5), 645–651 (2012)

    Article  CAS  Google Scholar 

  59. S. Cetinkaya, A. Ozon, N. Yordam, Diagnostic value of salivary cortisol in children with abnormal adrenal cortex functions. Horm. Res. 67(6), 301–306 (2007)

    Article  CAS  PubMed  Google Scholar 

  60. S.K. Baid, N. Sinaii, M. Wade, D. Rubino, L.K. Neiman, Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism. J. Clin. Endocrinol. Metab. 92(8), 3102–3107 (2007)

    Article  CAS  PubMed  Google Scholar 

  61. I. Perogamvros, L.J. Owen, B.G. Keevil, G. Brabant, P.J. Trainer, Measurement of salivary cortisol with liquid chromatography-tandem mass spectrometry in patients undergoing dynamic endocrine testing. Clin. Endocrinol. 72(1), 17–21 (2010)

    Article  CAS  Google Scholar 

  62. P. Restituto, J.C. Galofre, M.J. Gil, C. Mugueta, S. Santos, J.L. Monical, N. Varo, Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders. Clin. Biochem. 41(9), 688–692 (2008)

    Article  CAS  PubMed  Google Scholar 

  63. J.Y. Chon, H.S. Moon, Salivary cortisol concentration changes after epidural steroid injection. Pain. Phys. 15(6), 461–466 (2012)

    Google Scholar 

  64. J.W. Findling, H. Raff, Cushing’s syndrome:important issues in diagnosis and management. J. Clin. Endocrinol. Metab. 91(10), 3746–3753 (2006)

    Article  CAS  PubMed  Google Scholar 

  65. L.K. Nieman, B.M. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93(5), 1526–1540 (2008)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  66. G. Arnaldi, A. Angeli, A.B. Atkinson, X. Bertagna, F. Cavagnini, G.P. Chrousos, G.A. Fava, J.W. Findling, R.C. Gaillard, A.B. Grossman, B. Kola, A. Lacroix, T. Mancini, F. Mantero, J. Newell-Price, L.K. Nieman, N. Sonino, M.L. Vance, A. Giustina, M. Boscaro, Diagnosis and complications of Cushing’s syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 88(12), 5593–5602 (2003)

    Article  CAS  PubMed  Google Scholar 

  67. B.J. Bloom, L.C. Miller, L.B. Tucker, A.J. Alario, J.G. Schaller, Intra-articular corticosteroids in juvenile chronic arthritis. Arthritis 39, S46 (1997)

    Google Scholar 

  68. S. Kumar, R.J. Singh, A.M. Reed, A.N. Lteif, Cushing’s syndrome after intra-articular and intradermal administration of triamcinolone acetanoiode in three pediatric patients. Pediatrics 113(6), 1820–1824 (2004)

    Article  PubMed  Google Scholar 

  69. J.S. Gondwe, J.E. Davidson, S. Deeey, J. Sills, A.G. Cleary, Secondary Cushing’s syndrome in children with juvenile idiopathic arthritis following intra-articular triamcinolone acetonide administration. Rheumatology 44(11), 1457–1458 (2005)

    Article  CAS  PubMed  Google Scholar 

  70. T.L. Jansen, E.N.van Roon, Four cases of a secondary Cushingoid state following local triamcinolone acetonide (Kenacort) injection. Neth. J. Med. 60(3), 151–153 (2002)

    PubMed  Google Scholar 

  71. S.M. Tuel, J.M. Meythaler, L.L. Cross, Cushing’s syndrome from epidural methylprednisolone. Pain 40(1), 81–84 (1990)

    Article  CAS  PubMed  Google Scholar 

  72. M.H. Horani, A.B. Silverberg, Secondary Cushing’s syndrome after a single epidural injection of corticosteroid. Endocr. Pract. 11(6), 408–410 (2005)

    Article  PubMed  Google Scholar 

  73. J. Kay, J.W. Findling, H. Raff, Epidural triamcinolone suppresses the pituitary-adrenal axis in human subjects. Anesth. Analg. 79(3), 501–505 (1994)

    CAS  PubMed  Google Scholar 

  74. J. Leary, A. Swislocki, Hypothalamic-pituitary-adrenal suppression and iatrogenic cushing’s syndrome as a complication of epidural steroid injections. Case. Rep. Endocrinol. 2013, 617042 (2013)

    PubMed Central  PubMed  Google Scholar 

  75. C. Schwarze-Zander, D. Klingmuller, J. Klumper, C.P. Strassburg, J.K. Rockstroh, Triamcinolone and ritonavir leading to drug-induced Cushing syndrome and adrenal suppression:description of a new case and review of the literature. Infection 41(6), 1183–1187 (2013)

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Amanda Mendelsohn for providing the illustration from the Center for Medical Art and Photography, Cleveland Clinic Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philip C. Johnston.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Johnston, P.C., Lansang, M.C., Chatterjee, S. et al. Intra-articular glucocorticoid injections and their effect on hypothalamic–pituitary–adrenal (HPA)-axis function. Endocrine 48, 410–416 (2015). https://doi.org/10.1007/s12020-014-0409-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-014-0409-5

Keywords

Navigation